HIF-1α signaling regulates LSC maintenance, quiescence and therapy sensitivity by promoting expression of VEGF, CXCR4, CXCL12 and SCF on both the AML blasts and the stromal cells (139). This evidence concerns the gene CXCR4 and acute myeloid leukemia.